Observer Observer Logo

Pfizer

  • Business
  • Finance
  • Tech
  • Media
  • Lifestyle
  • Arts
  • Entertainment
Newsletters
  • Entertainment
    • What to Watch
    • Books
    • Reviews
    • Movies
    • TV
    • Theater
    • Music
  • Arts
    • Visual Art
  • Business
    • Management
    • Media
    • Technology
    • Space
  • Lifestyle
    • Fashion
    • Travel
    • Beauty
  • About
    • Masthead
    • Editorial Ethics and Guidelines
    • Advertise With Us
    • Observer Advertising Guidelines
Events Newsletters

Pfizer

The FDA Has Approved an Omicron Booster That Could Be Administered as Soon as Next Week

Now that the FDA has approved the Omicron booster, the next step is for the CDC to review it.
By Rachel Millman

Pfizer-BioNTech Begins Clinical Trial of Omicron-Targeted Vaccine

It's still unclear whether an Omicron-specific vaccine is needed.
By Sissi Cao

How Well Do COVID-19 Treatments Work Against Omicron? Here’s What Drugmakers Say

Most antivirals will likely continue to work against omicron, based on early lab tests and computer modeling.
By Sissi Cao

Omicron-Specific Vaccines Can Be Ready in 100 Days, Pfizer and Moderna CEOs Say

By Sissi Cao

FDA, CDC Clear 3rd Dose of Pfizer and Moderna COVID-19 Vaccine for All Adults

By Sissi Cao

Yes, You Can Probably Mix and Match Different COVID-19 Vaccines According to Studies

By Sissi Cao

FDA to Vote on Moderna, J&J Booster Shot, Discuss Mixing and Matching Vaccines

By Sissi Cao

Merck Is Not the Only COVID Pill—Here Are 3 Other Antivirals Near the Finish Line

By Sissi Cao

Merck’s Groundbreaking COVID-19 Pill Triggers Global Vaccine Stock Sell-Off

By Sissi Cao

Sanofi Abandons mRNA COVID-19 Vaccine in the Face of Moderna, Pfizer Dominance

By Sissi Cao

Here’s Who Should Get a 3rd Pfizer Shot According to the CDC’s Latest Recommendation

By Sissi Cao

CDC Convenes to Decide Who Will Get Pfizer Booster Following FDA’s Surprise Vote

By Sissi Cao

Pfizer’s Science Chief Explains Why Its Vaccine Contains Lower mRNA Dose Than Moderna’s

By Sissi Cao

More Studies Suggest Moderna’s COVID-19 Vaccine Is More Effective Than Pfizer’s

By Sissi Cao

How Soon Will the FDA Fully Approve Moderna and J&J Vaccines?

By Sissi Cao

FDA Authorizes 3rd COVID-19 Booster Shot—Here Are the Side Effects to Expect

By Sissi Cao

Moderna Vaccine Is Better Than Pfizer-BioNTech at Tackling Delta Variant, US Study Found

By Sissi Cao

Pfizer, Moderna Hike COVID-19 Vaccine Prices by as Much as 26%—Here’s Why

By Sissi Cao

How Long Does COVID-19 Vaccine Protection Last? New Study Raises Red Flags

By Sissi Cao

When Will You Need a COVID-19 Booster Shot? Top Doctors, Vaccine Makers Explain

By Sissi Cao

Pharma CEOs React to Waiving COVID-19 Vaccine Patent Protection, Sinking Stock

By Sissi Cao

COVID-19 Vaccines for Children: What You Can Expect for Different Age Groups

By Sissi Cao

Novavax’s ‘Secret Ingredient’ In COVID-19 Vaccine Also Works in Preventing Malaria

By Sissi Cao

Is Novavax the Next COVID-19 Vaccine on the Block? How It Works & Why It’s Important

By Sissi Cao
More
  • Contact
  • About
  • Advertise
  • Advertising Guidelines
  • Editorial Ethics
  • Sitemap
  • Newsletters
  • RSS Feeds
  • Privacy
  • Terms
  • Cookie Settings
  • Do not sell my data
Powered by WordPress VIP

We noticed you're using an ad blocker.

We get it: you like to have control of your own internet experience.
But advertising revenue helps support our journalism.

To read our full stories, please turn off your ad blocker.
We'd really appreciate it.

How Do I Whitelist Observer?

How Do I Whitelist Observer?

Below are steps you can take in order to whitelist Observer.com on your browser:

For Adblock:

Click the AdBlock button on your browser and select Don't run on pages on this domain.

For Adblock Plus on Google Chrome:

Click the AdBlock Plus button on your browser and select Enabled on this site.

For Adblock Plus on Firefox:

Click the AdBlock Plus button on your browser and select Disable on Observer.com.

Then Reload the Page